Articles

Arriving soon: rotatable cryogen-free MRI

University of Nottingham Ningbo China plans to introduce world’s first 1.5T rotatable dual-gesture cryogen-free MRI
Written byDDNews Staff
| 2 min read

NINGBO, China—A collaboration between University of Nottingham Ningbo China (UNNC), Ningbo Gaosi Superconducting Technology Co. Ltd., Ningbo XinGaoYi Medical Equipment Co. Ltd., the First Affiliated Hospital of Zhejiang University School of Medicine and China Academy of Sciences University Ningbo Hwamei Hospital will soon introduce the world to new magnetic resonance imaging (MRI) technology.

The collaboration’s research project, entitled “Development of 1.5 T cryogen-free superconducting magnets,” has recently achieved a phased breakthrough. The UNNC is expected to introduce the world’s first 1.5T rotatable dual-gesture scanner in the near future.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue